Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.03
Delayed Data
As of Feb 05
 -0.07 / -0.63%
Today’s Change
6.36
Today|||52-Week Range
21.16
+4.65%
Year-to-Date

Today’s Trading

Previous close11.10
Today’s open11.05
Day’s range10.34 - 11.73
Volume1,619,867
Average volume (3 months)951,410
Market cap$1.3B
Dividend yield9.07%
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+87.22%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-4.26-9.69%
TXMDTherapeuticsMD Inc-0.35-5.19%
ITCIIntra-Cellular Thera...-4.01-12.30%
IRWDIronwood Pharmaceuti...-0.65-7.16%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers